Bharat Bio successfully completes Phase III trials of new oral...

Dununu.com Dununu

Sponsorizzato

Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol

RSS Feed National

Posted

98

Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.

Read Full Article

Effettua l'accesso per mettere mi piace, condividere e commentare!

'I did it': US woman confesses to 1997 baby's death on camera, recounts chilling moments

In a shocking turn of events, a 52-year-old US woman confessed to the 1997 murder of her newborn...

By 0 0

UPSC CSE prelims 2025 answer key released for GS Paper 1 and 2: Check details here

By 0 4

Apple’s biggest contract manufacturer Foxconn readies 300-acre iPhone making campus in India with dorms for 30,000 employees

Foxconn is constructing a 300-acre campus in India, including dormitories for 30,000 workers....

By 0 11

Lights, video, confrontation - Trump's meeting with South African leader takes dramatic turn

Donald Trump hosted Cyril Ramaphosa in the Oval Office. Trump raised concerns about attacks on...

By 0 15

IPL playoffs history: MI pip RCB, inch closer to CSK's record

Mumbai Indians secured the final playoff spot in IPL 2025 after a dominant victory over Delhi...

By 0 15